Dr. Ulrike Herr
Partner
Maiwald
Gevorg Grigoryan
Co-Founder & CTO
Generate Biomedicines
Eva Fast
Senior Principal Computational Biologist
Pfizer
Dr. Marc Clement
Co-Founder/Chief Innovation Officer
CyDen Ltd
Etienne Legangneux
CEO
Vet AI
With over 15 years of expertise in pet care and consumer brands, Etienne has combined private equity and operational leadership across global markets. He was involved in investments in leading companies such as Edgard & Cooper and Vita Coco, before co-founding Wolf Spring, a U.S. pet supplement business. He is now leading Vet-AI, where technology and veterinary expertise converge to deliver innovative solutions for pet owners and industry stakeholders.
Karine Sellam
VP Global Head of Business Development
Zoetis
- Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health.
- Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness.
- Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
Oliver Bates
Chief Executive Officer
Viramal